DUBLIN--(BUSINESS WIRE)--The "Global Endocrine Function Testing Market Country Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.
This report is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.
During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
Key Topics Covered:
2. Worldwide Market and Technology Overview
3. Design Criteria for Decentralized Testing Products
4. Alternative Market Penetration Strategies
5. Testing Markets
6. Competitive Assessments
- Abbott Laboratories
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Thermo Fisher
For more information about this report visit https://www.researchandmarkets.com/research/bblnlw/global_endocrine?w=4